Fewer Than Half of Accelerated Approval Drugs Showed Clinical Benefit in Confirmatory Trials After Five Years
SAN DIEGO – Of the 46 cancer drugs that the U.S. Food and Drug Administration (FDA) granted accelerated approval...
SAN DIEGO – Of the 46 cancer drugs that the U.S. Food and Drug Administration (FDA) granted accelerated approval...
PHILADELPHIA – The American Association for Cancer Research (AACR) Foundation today announced its FIFTY for FIFTY fundraising and awareness...
PHILADELPHIA – Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had...
PHILADELPHIA – The transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered...
SAN ANTONIO — The addition of the anti-PD-1 immunotherapeutic pembrolizumab (Keytruda) to neoadjuvant chemotherapy increased the rates of pathologic complete response (pCR)...
Submission deadline is Friday, December 4, 2020 PHILADELPHIA — The American Association for Cancer Research (AACR) is now accepting...
Awardees will receive $5,000 unrestricted cash prize PHILADELPHIA – The American Association for Cancer Research (AACR) is inviting journalists...
PHILADELPHIA – Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer...
SAN DIEGO – The PD-1/CTLA-4 bispecific antibody cadonilimab plus chemotherapy improved progression-free survival and overall survival in patients with...
Elacestrant is the first oral selective estrogen receptor degrader to show clinical benefit over standard of care in a...
Treatment de-escalation may be an option for patients whose lymph nodes become cancer free after neoadjuvant treatment SAN ANTONIO...
Resource reflects transition from a mostly microscopy-driven to a molecularly driven classification system PHILADELPHIA – The first classification of...
Letters of Intent to participate in the program and related workshop due May 28 PHILADELPHIA – Today, the American...
PHILADELPHIA — The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has...
Now accepting submissions for publication PHILADELPHIA – The American Association for Cancer Research (AACR) is launching a new journal,...
PHILADELPHIA – The American Association for Cancer Research (AACR) Foundation today announced a fundraising partnership with The Battle Cancer...
Vaccination given in combination with autologous stem cell transplant was associated with long-term disease control PHILADELPHIA – A dendritic...
SAN ANTONIO – Non-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had worse outcomes compared to...
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Some mammographic features are associated with increased breast cancer risk PHILADELPHIA – An analysis of a large Swedish cohort...
Single test could identify one prognostic and seven predictive biomarkers in blood PHILADELPHIA – Guardant360, a liquid biopsy test...
Researchers partnered with Gift of Life Michigan to analyze healthy pancreata from deceased donors PHILADELPHIA – Pancreatic intraepithelial neoplasia...
“SAN ANTONIO – Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk and...
Awardees to receive $5,000 cash prize PHILADELPHIA — The American Association for Cancer Research (AACR) is inviting journalists to...
Subgroup analysis suggested the treatment may benefit patients with nonbasal-like disease SAN ANTONIO Treating patients who had early-stage triple-negative...
Findings have implications for future cancer clinical trial design involving immune checkpoint inhibitors PHILADELPHIA – Independent drug action, not...
Survey found that most people are open to participating, and motivation varied by racial and ethnic group ORLANDO, Fla....
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...
Concurrent treatment with PI3K pathway inhibitors may benefit at-risk patients SAN ANTONIO – Uterine cancers that developed in patients...
Patients who would not have otherwise been candidates for surgery achieved successful resection PHILADELPHIA – Patients with liver cancer...